Placeholder canvas

Qualcomm pays $975 mn to settle China antitrust probe

Date:

US mobile chip titan Qualcomm on Monday said it will pay nearly a billion dollars as part of a deal to end a long-running antitrust probe in China.

Under terms of an agreement with China’s National Development and Reform Commission, Qualcomm will modify its business practices in that country and pay 6.088 billion yuan (about $975 million), the California based chip maker announced.

The agreement will end the commission’s investigation into Qualcomm under the auspices of China’s Anti-Monopoly Law, according to the company.

“We are pleased that the investigation has concluded and believe that our licensing business is now well positioned to fully participate in China’s rapidly accelerating adoption of our 3G/4G technology,” Qualcomm president Derek Aberle said in a release.

Qualcomm said that as part of the settlement it modified the terms under which it licenses its mobile chip technology in China.

Beijing confirmed early last year that a probe of Qualcomm was under way.

The NDRC, one of China’s three anti-trust watchdogs, said the investigation was triggered by complaints by unnamed Chinese industry players had triggered that US companies were abusing their market dominance to charge high prices.

Chinese authorities about two years ago launched sweeping investigations into alleged malpractice by foreign firms in various sectors including pharmaceuticals and baby formula.

Qualcomm shares ended the trading day up slightly and then rose more than a percent to $68.10 in after-market activity.

Qualcomm chief executive Steve Mollenkopf said the deal “has removed the uncertainty surrounding our business in China, and we will now focus our full attention and resources on supporting our customers and partners in China and pursuing the many opportunities ahead.”

Qualcomm, whose chips are used in a large number of mobile phones and devices, agreed to charge royalties of five percent for 3G devices and 3.5 percent for 4G devices, and will not condition the sale of chips on “unreasonable” terms, according to the agreement.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

AstraZeneca Withdraws COVID-19 Vaccine Globally Following Rare Side Effect Concerns: Report

Cambridge: Pharmaceutical giant AstraZeneca has announced the worldwide withdrawal...

NewsMobile Morning Brief

Lok Sabha Polls: Phase 3 Records 63.47% Voter Turnout...

Lok Sabha Polls: Phase 3 Records 63.47% Voter Turnout | TOP UPDATES

New Delhi: The third phase of the 18th Lok...

IPL 2024: Khaleel, Mukesh, Kuldeep Shine As DC Win By 20 Runs Against RR

New Delhi: Khaleel Ahmed, Kuldeep Yadav, and Mukesh Kumar...